Effect of variation in BDNF Val66Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders

Drug and Alcohol Dependence

Volumn 148, Issue , 2015, Pages 150-157

  Jamal, Mumtaz ^a   Van der Does, Willem ^a,b   Penninx, Brenda W J H ^b,c,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anxiety disorders; BDNF Val66Met polymorphism; Depression; Nicotine dependence; Severity of symptoms; Smoking

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; NICOTINE; VALINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ANXIETY DISORDER; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; ANXIETY DISORDERS; DEPRESSIVE DISORDER; GENETICS; MIDDLE AGED; NETHERLANDS; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TOBACCO USE DISORDER;

ADULT; ANXIETY DISORDERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; VALINE;

EID: 84923080130     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.12.032     Document Type: Article

References (71)

1. Anttila S., Huuhka K., Huuhka M., Rontu R., Hurme M., Leinonen E., Lehtima T. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J. Neural Transm. 2007, 114:1065-1068.
2. Audrain-McGovern J., Lerman C., Wileyto E.P., Rodriguez D., Shields P.G. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am. J. Psychiatry 2004, 161:1224-1230.
3. Babor T.F., Kranzler H.R., Lauerman R.J. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict. Behav. 1989, 14:139-157.
4. 66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 2006, 6:79-85.
5. Beck A.T., Brown G., Epstein N., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 1988, 56:893-897.
6. Bjorngaard J.H., Gunnell D., Elvestad M.B., Smith G.D., Skorpen F., Krokan H., Vatten L., Romundstad P. The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Psychol. Med. 2013, 43:711-719.
7. Boomsma D.I., Willemsen G., Sullivan P.F., Heutink P., Meijer P., Sondervan D., Kluft C., Smit G., Nolen W.A., Zitman F.G., Smit J.H., Hoogendijk W.J., van Dyck R., de Geus E.J.C., Penninx B.W.J.H. Genome-wide association of major depression: description of samples for the GAIN major depressive disorder study: NTR and NESDA biobank projects. Eur. J. Hum. Genet. 2008, 16:335-342.
8. Breslau N., Kilbey M.M., Andreski P. Nicotine dependence, major depression and anxiety in young adults. Arch. Gen. Psychiatry 1991, 48:1069-1074.
9. Breslau N., Kilbey M.M., Andreski P. Nicotine dependence and majordepression: new evidence from a prospective investigation. Arch. Gen. Psychiatry 1993, 50:31-35.
10. Brugha T., Bebbington P., Tennant C., Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol. Med. 1985, 15:189-194.
11. Burling A.S., Burling T.A. A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine Tob. Res. 2003, 5:625-633.
12. Caldwell T.M., Rodgers B., Jorm A.F., Christensen H., Jacomb P.A., Korten A.E., Lynskey M.T. Patterns of association between alcohol consumption and symptoms of depression and anxiety in young adults. Addiction 2002, 97:583-594.
13. Chaiton M.O., Cohen J.E., O'Loughlin J., Rehm J. A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health 2009, 9:1-11.
14. Chen L., Lawlor D.A., Lewis S.J., Yuan W., Abdollahi M.R., Timpson N.J., Day I.N.M., Ebrahim S., Smith G.D., Shugart Y.Y. Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am. J. Med. Genet., B: Neuropsychiatric Genet. 2008, 147B:814-821.
15. Colzato L.S., van der Does A.J.W., Kouwenhoven C., Elzinga B.M., Hommel B. BDNF Val66Met polymorphism is associated with higher anticipatorycortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 2011, 36:1562-1569.
16. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 1997, 17:2295-2313.
17. Cosci F., Knuts I.J.E., Abrams K., Griez E.J.L., Schruers K.R.J. Cigarette smoking and panic: a critical review of the literature. J. Clin. Psychiatry 2010, 71:606-615.
18. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U.L.F., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exercise 2003, 35:1381-1395.
19. Da Silva M.A., Singh-Manoux A., Brunner E.J., Kaffashian S., Shipley M.J., Kivimaki M., Nabi H. Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur. J. Epidemiol. 2012, 27:537-546.
20. Duncan L.E., Hutchison K.E., Carey G., Craighead W.E. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J. Affect. Disord. 2009, 115:215-219.
21. Edwards A.C., Maes H.H., Pedersen N.L., Kendler K.S. A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence. Psychol. Med. 2011, 41:395-405.
22. Fergusson D.M., Lynskey M.T., Horwood L.J. Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds. Arch. Gen. Psychiatry 1996, 53:1043-1047.
23. 66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007, 64:410-416.
24. 66Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict. Biol. 2013, 18:836-845.
25. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
26. Jamal M., van der Does A.J.W., Cuijpers P., Penninx B.W.J.H. Association of smoking and nicotine dependence with severity and course of symptoms inpatients with depressive or anxiety disorder. Drug Alcohol Depend. 2012, 126:138-146.
27. Keller M. Gene×environment interaction studies have not properly controlled forpotential confounders: the problem and the (simple) solution. Biol. Psychiatry 2014, 75:18-24.
28. Kendler K.S., Neale M.C., MacLean C.J., Heath A.C., Eaves L.J., Kessler R.C. Smoking and major depression: a causal analysis. Arch. Gen. Psychiatry 1993, 50:36-43.
29. Korhonen T., Broms U., Varjonen J., Romanov K., Koskenvuo M., Kinnunen T., Kaprio J. Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins. Psychol. Med. 2007, 37:705-715.
30. 66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004, 49:178-181.
31. 66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology 2007, 190:433-439.
32. Leach L.S., Christensen H., Windsor T.D., Butterworth P., Mackinnon A.J. Gender differences in depression and anxiety across the adult lifespan: the role of psychosocial mediators. Soc. Psychiatry Psychiatr. Epidemiol. 2008, 43:983-998.
33. 66Met polymorphism and posttraumatic stress disorder. Stress Health 2006, 22:115-119.
34. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989, 341:149-152.
35. Lerman C., Caporaso N., Main D., Audrain J., Boyd N.R., Bowman E.D., Shields P.G. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 1998, 17:56-62.
36. Lyons M., Hitsman B., Xian H., Panizzon M.S., Jerskey B.A., Santangelo S., Grant M.D., Rende R., Eisen S., Eaves L., Tsuang M.T. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob. Res. 2008, 10:97-108.
37. Maisonpierre P.C., Lebeau M.M., Espinosa R., Ip N.Y., Belluscio L., Delamonte S.M., Squinto S., Furth M.E., Yancopoulos G.D. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991, 10:558-568.
38. Manley M.J., de Jonge P., Kershaw T.S., Desai R.A., Lin H.Q., Kasl S.V. Association of major depression with subtypes of nicotine dependence found among adult daily smokers: a latent class analysis. Drug Alcohol Depend. 2009, 104:126-132.
39. Marks I.M., Mathews A.M. Brief standard self-rating for phobic patients. Behav. Res. Ther. 1979, 17:263-267.
40. McCaffery J.M., Stanton C., Papandonatos G.D., Lloyd-Richardson E.E., Niaura R. Depressive symptoms and cigarette smoking in twins from the National Longitudinal Study of Adolescent Health. Health Psychol. 2008, 27:S207-S215.
41. 66Met polymorphism and smoking. Neurosci. Lett. 2008, 442:30-33.
42. Morrell H.E.R., Cohen L.M. Cigarette smoking, anxiety, and depression. J. Psychopathol. Behav. Assess. 2006, 28:283-297.
43. Moylan S., Jacka F.N., Pasco J.A., Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders? A critical review of biological pathways. Brain Behav. 2013, 3:302-326.
44. Otowa T., Shimada T., Kawamura Y., Liu X., Inoue K., Sugaya N., Minato T., Nakagami R., Tochigi M., Umekage T., Kasai K., Kato N., Tanii H., Okazaki Y., Kaiya H., Sasaki T. No association between the brain-derived neurotrophic factor gene and panic disorder in Japanese population. J. Hum. Genet. 2009, 54:437-439.
45. Pedersen W., von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction 2009, 104:129-137.
46. Penninx B.W.J.H., Beekman A.T.F., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., Cuijpers P., de Jong P.J., van Marwijk H.W.J., Assendelft W.J.J., van der Meer K., Verhaak P., Wensing M., de Graaf R., Hoogendijk W.J., Ormel J., Van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int. J. Methods Psychiatr. Res. 2008, 17:121-140. NESDA Research Consortium.
47. 66Met polymorphism and variation in humancortical morphology. J. Neurosci. 2004, 24:10099-10102.
48. Pillay A.L., Sargent C.A. Relationship of age and education with anxiety, depression, and hopelessness in a South African community sample. Percept. Mot. Skills 1999, 89:881-884.
49. Pomerleau C.S., Carton S.M., Lutzke M.L., Flessland K.A., Pomerleau O.F. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict. Behav. 1994, 19:33-39.
50. Reichborn-Kjennerud T., Roysamb E., Tambs K., Torgersen S., Kringlen E., Magnus P., Harris J.R. Genetic and environmental influences on the association between smoking and panic attacks in females: a population-based twin study. Psychol. Med. 2004, 34:1271-1277.
51. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The inventoryof depressive symptomatology (IDS): psychometric properties. Psychol. Med. 1996, 26:477-486.
52. Schumacher J., Abou Jamra R., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmal C., Hofels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nothen M.M., Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58:307-314.
53. Shimizu E., Hashimoto K., Koizumi H., Kobayashi K., Itoh K., Mitsumori M., Ohgake S., Okamura N., Koike K., Matsuzawa D., Zhang L., Kumakiri C., Nakazato M., Komatsu N., Iyo M. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:708-712.
54. Spinhoven P., Elzinga B.M., Hovens J.G.F.M., Roelofs K., van Oppen P., Zitman F.G., Penninx B.W.J.H. Positive and negative life events and personality traits in predicting course of depression and anxiety. Acta Psychiatr. Scand. 2011, 124:462-473.
55. Strong D.R., Cameron A., Feuer S., Cohn A., Abrantes A.M., Brown R.A. Single versus recurrent depression history: differentiating risk factors among current US smokers. Drug Alcohol Depend. 2010, 109:90-95.
56. Sullivan P.F., Daly M.J., Ripke S., Lewis C.M., Lin D.-Y., Wray N.R., Neale B., Levinson D.F., Breen G., Byrne E.M., Rietschel M., Hoogendijk W., et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 2013, 18:497-511.
57. 66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J. Psychiatr. Res. 2007, 41:404-409.
58. Tizabi Y., Hauser S.R., Tyler K.Y., Getachew B., Madani R., Sharma Y., Manaye K.F. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:62-69.
59. 66Met polymorphism at BDNFgene and anxiety disorders in a community sample of children and adolescents. Neurosci. Lett. 2011, 502:197-200.
60. Vanzuuren F.J. The fear questionnaire: some data on validity, reliability, and layout. Br. J. Psychiatry 1988, 153:659-662.
61. 66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol. Psychiatry 2010, 15:260-271.
62. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
63. Wang Z.R., Zhou D.F., Cao L.Y., Tan Y.L., Zhang X.Y., Li J., Lu L., Wu G.Y., Kosten T.A., Kosten T.R. Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr. Res. 2007, 97:299-301.
64. Will C.C., Aird F., Redei E.E. Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol. Psychiatry 2003, 8:925-932.
65. Wittchen H.-U., Robins L.N., Cottler L.B., Sartorius N., Burke J.D., Regier D. Cross-cultural feasibility, reliability, and sources of variance of the composite international diagnostic interview (CIDI): the multicentre WHO/ADAMHA field trials. Br. J. Psychiatry 1991, 159:645-653.
66. Yzerbyt V.Y., Muller D., Judd C.M. Adjusting researchers' approach to adjustment: on the use of covariates when testing interactions. J. Exp. Soc. Psychol. 2004, 40:424-431.
67. Zhang-James Y., Middleton F.A., Faraone S.V. Genetic architecture of Wistar-Kyoto rat and spontaneously hypertensive rat substrains from different sources. Physiol. Genomics 2013, 45:528-538.
68. Zhang K., Yang C., Xu Y., Sun N., Yang H., Liu J., Xu Q., Shen Y. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J. Neural Transm. 2010, 117:393-401.
69. 66Met variant and smoking in a Chinese population. PLoS ONE 2012, 7:1-5.
70. Zhao G., Ford E.S., Dhingra S., Li C., Strine T.W., Mokdad A.H. Depressionand anxiety among US adults: associations with body mass index. Int. J. Obes. 2009, 33:257-266.
71. Zvolensky M.J., Feldner M.T., Leen-Feldner E.W., McLeish A.C. Smoking and panic attacks, panic disorder, and agoraphobia: a review of the empirical literature. Clin. Psychol. Rev. 2005, 25:761-789.